Furthermore, breast cancer cells MCF7 (CD24+/CD44−) and MDA-MB-231 (CD24−/CD44+) were continuously exposed to exogenous LIF and analyzed for CD24/CD44 expression variations over time. Here, CD44 is linked to breast carcinoma.